Etty N Benveniste

Title: Etty N Benveniste: Innovator in Modulating Inflammatory Cytokines

Introduction

Etty N Benveniste is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of neuroscience, particularly in the modulation of inflammatory cytokines in the central nervous system (CNS). Her innovative work has the potential to impact therapeutic approaches for various neurological conditions.

Latest Patents

Etty N Benveniste holds 1 patent for her invention titled "Methods of modulating inflammatory cytokines in the CNS using TGF-.beta." This patent discloses methods for modulating the expression of inflammatory cytokines in the CNS by administering an effective amount of TGF-.beta. The methods include suppressing pro-inflammatory cytokines and inducing anti-inflammatory cytokines in the CNS, showcasing her expertise in this critical area of research.

Career Highlights

Etty is associated with Celtrix Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at the company reflects her commitment to translating scientific discoveries into practical applications that can benefit patients.

Collaborations

Etty collaborates with Joseph A Carlino, enhancing her research through teamwork and shared expertise. Their partnership exemplifies the importance of collaboration in driving innovation in the field of neuroscience.

Conclusion

Etty N Benveniste's contributions to the modulation of inflammatory cytokines in the CNS highlight her role as a leading inventor in her field. Her innovative methods and dedication to research continue to pave the way for advancements in neurological therapies.